Insulet | PODD - Ebitda

Биржевая цена
147.46
Изменение за день
-1.22 -0.82%
Ежемесячно
-26.81%
Ежегодный
-54.59%
Q2 прогноз
144.50




Ebitda Изменить Дата
Abbott USD 3.27B 178M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Avanos Medical USD 13M 3M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cardinal Health USD 1.09B 109M 2026-03
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
ICU Medical USD 98.68M 489K 2026-03
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
J&J USD 7.19B 2.32B 2025-12
Masimo USD 85.5M 6.4M 2026-03
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Solventum Corp USD 437M 0 2026-03
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12